Autopsy report · NCT02407314

Ticagrelor and Peripheral Arterial Disease

“AZ discontinued study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 1 year 7 months before it stopped.
• 26 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Arkansas Heart Hospital

Sponsor type

University, hospital or other

Conditions

Peripheral Arterial Disease

Interventions

Percutaneous Peripheral Intervention; Optical Coherence Tomography; Ankle Brachial Index; Six minute walk distance; Aspirin; Aspirin + Ticagrelor

Participants

26

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.